Atul R. Mahableshwarkar

A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

Atul R. Mahableshwarkar, John Zajecka, W. Jacobson et al. · Neuropsychopharmacology · 2015 · 309 citations · Full text

Medicine, Pharmacology, Psychiatry +17

A Randomized, Double-Blind, Placebo-Controlled 8-Week Trial of the Efficacy and Tolerability of Multiple Doses of Lu AA21004 in Adults With Major Depressive Disorder

Neven Henigsberg, Atul R. Mahableshwarkar, Paula L. Jacobsen et al. · The Journal of Clinical Psychiatry · 2012 · 151 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder

Atul R. Mahableshwarkar, Paula L. Jacobsen, Yinzhong Chen · Current Medical Research and Opinion · 2012 · 135 citations

Medicine, Pharmacology, Pharmacotherapy +16

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Vortioxetine 10 mg and 20 mg in Adults With Major Depressive Disorder

Paula L. Jacobsen, Atul R. Mahableshwarkar, Michael Serenko et al. · The Journal of Clinical Psychiatry · 2015 · 119 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction

Paula L. Jacobsen, Atul R. Mahableshwarkar, Y. Chen et al. · The Journal of Sexual Medicine · 2015 · 117 citations

Medicine, Pharmacology, Psychiatry +12